The Technical Analyst
Cosmos Holdings Inc. [COSM]
Exchange: PNK Industry: Drug Manufacturers
Cosmos Holdings Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.54% $0.608
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10.29 mill |
| EPS: | -4.23 |
| P/E: | -0.140 |
| Earnings Date: | May 15, 2024 |
| SharesOutstanding: | 16.93 mill |
| Avg Daily Volume: | 0.285 mill |
| RATING 2024-04-18 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.140 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.140 | industry: PE -6.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.539 - 0.677 ( +/- 11.35%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-16 | Siokas Grigorios | Buy | 60 000 | Common Stock, par value $.001 |
| 2023-12-22 | Aslidis Anastasios | Sell | 200 | Common Stock, $.001 par value |
| 2023-10-24 | Terzis Georgios | Buy | 51 485 | Common Stock, $.001 par value |
| 2023-10-12 | Siokas Grigorios | Buy | 6 712 | Common Stock, par value $0.001 per share |
| 2023-09-18 | Bhutawala Suhel | Sell | 0 | Common Stock, $.001 par value |
| INSIDER POWER |
|---|
| 86.47 |
| Last 96 transactions |
| Buy: 36 943 515 | Sell: 4 728 118 |
Forecast:
16:00 - $0.608
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.608
Forecast 2: 16:00 - $0.608
Forecast 3: 16:00 - $0.608
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.608 (-3.54% ) |
| Volume | 0.0763 mill |
| Avg. Vol. | 0.285 mill |
| % of Avg. Vol | 26.79 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For COSM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
COSM
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Latest Press Releases
2024-03-21 09:45:00 - Press Release
Cosmos Health Commences Development Of Cloudscreen 2.0, The New Iteration Of Its Next Generation Ai Drug Repurposing Platform
Chicago, il / accesswire / march 21, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the initiation of the development of cloudscreen 2.0, the new iteration of its groundbreaking artificial intelligence (ai) drug repurposing platform. as previously announced, on january 23, 2024, cosmos health completed the acquisition of cloudscreen.
2024-03-19 10:10:00 - Press Release
Cosmos Health To Receive Regulatory Approval For C-scrub Disinfectant In The Uk, Obtains Initial Purchase Order; Explores Opportunities Outside Eu, Eyeing Global $36bn+ Market
Chicago, il / accesswire / march 19, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today it is in the final stages of securing regulatory approval to sell its biocide disinfectant hand soap, c-scrub wash 4% chg ("c-scrub"), in the united kingdom (uk), and has obtained its inaugural purchase order. cosmos health expects to obtain all necessary registration approvals from the uk's health security agency (hsa), an executive agency of the department of health and social care.
2024-03-18 09:25:00 - Press Release
Cosmos Health Receives Regulatory Approval To Sell Sky Premium Life Products In $1.9bn Uae Nutritional Supplements Market; Secures Initial Purchase Orders
Chicago, il / accesswire / march 18, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received regulatory approval to sell its sky premium life® vitamins and food supplements in the united arab emirates (uae) market, and has obtained its inaugural purchase orders. cosmos health has obtained consumer product registration certificates ("registration certificates") from the public health & safety department of the government of dubai.
2024-02-29 09:25:00 - Press Release
Cosmos Health Successfully Completes Acquisition Of Pharmatrade's Assets; Expects To Increase Fy 2024 Annual Revenue By Over $5 Million
Chicago, il / accesswire / february 29, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the successful acquisition of the distribution network owned by pharmatrade s.a. ("pharmatrade"), an established pharmaceutical wholesale company operating in greece.
2024-02-20 09:25:00 - Press Release
Cosmos Health Ceo, Greg Siokas, Purchases Shares In The Open Market, Showcasing His Confidence In The Company
Chicago, il / accesswire / february 20, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that on february 16, 2024, its ceo, mr. greg siokas, acquired a total of 60,000 shares of the company's common stock in the open market at an average price of $0.8301, for a total consideration of $49,806, demonstrating his strong belief in the company and unwavering dedication to its continuous development.
Latest News
2023-09-28 16:06:06 - InvestorPlace
Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done
The healthcare industry has historically provided significant returns to investors. And, it is currently boasting a compounding annual growth rate prediction of 10.4% until 2027.
2023-04-27 15:09:37 - PennyStocks
5 Hot Penny Stocks To Watch Before Next Week
5 penny stocks to watch. The post 5 Hot Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-05 07:42:01 - Seeking Alpha
Cosmos Health: Shareholder-Friendly News Abounds, Stock Still Undervalued
Things have started to heat up after January 17, 2023, when Cosmos unleashed a flurry of positive news, with a total of 6 major announcements made since then. Credit needs to be given to Cosmos management. It has been a series of positive shareholder-friendly actions.
2023-01-11 00:01:13 - Seeking Alpha
Cosmos Health: A Cash-Rich Small Cap With Significant Growth Ahead
In 2022, Cosmos' share price plummeted more than 90% as it was caught in the midst of market turmoil. The completion of a reverse stock split and official compliance with Nasdaq listing requirements have improved investor perception.
2023-01-06 12:27:27 - PennyStocks
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch
2022-12-19 13:41:00 - Market Watch
Cosmos Health stock tumbles, weighed down by $32.5 million registered direct offering
Cosmos Health Inc.'s stock pulled back Monday after the company announced the pricing of a $32.5 million registered direct offering, wiping away Friday's big gains.
2022-12-19 10:37:51 - InvestorPlace
Why Is Cosmos Health (COSM) Stock Down 58% Today?
Cosmos Health (NASDAQ: COSM ) stock is falling hard on Monday after the healthcare company's shares got a boost on Friday. That increase in price for COSM stock came alongside a couple of pieces of news from the company.
2022-12-16 17:17:00 - Market Watch
Cosmos Health stock rockets on reverse stock split
Cosmos Health Inc.'s stock price nearly tripled Friday as investors responded to the company's reverse stock split.
2022-12-16 11:06:42 - InvestorPlace
COSM Stock Alert: What to Know As Cosmos' Reverse Stock Split Takes Effect
Cosmos (NASDAQ: COSM ) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today. The name change saw the company moving from the Cosmos Holdings name to its new Cosmos Health name.
2022-12-16 06:00:00 - PennyStocks
Top Methods for Building A Penny Stocks Portfolio
Use these methods to find penny stocks The post Top Methods for Building A Penny Stocks Portfolio appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.